Here, EVI1 expression was found to be downregulated following knockdown of CEBPA in inv(3) AML cells, and mutation of the CEBPA binding site in the hijacked enhancer reduced enhancer activity58. The gene discussed is MECOM; the disease is acute myeloid leukemia.